EHS-COVID (352) Impact of COVID-19 on cancer services (8)

8 June, 2021

Dear HIFA Friends,

Further to the previous contributions, can I suggest also looking at a review (just published) that measures the impact on cancer care of the first wave of restrictions implemented in a wide selection of countries as the pandemic swept across the world in early 2020.

Although not completely comprehensive (there are a preponderance of reports from HICs) it is good read, and also chilling. It leaves us asking, "What lessons can we take that will help us protect cancer patients better in the future?"

Best regards,


HIFA profile: Mark Lodge is Director of Programme Development at the International Network for Cancer Treatment and Research, Oxford, UK. The INCTR is dedicated to helping to build capacity for cancer treatment and research in countries in which such capacity is presently limited, and thereby to create a foundation on which to build strategies designed to lessen the suffering, limit the number of lives lost, and promote the highest quality of life for children and adults with cancer in these countries, and to increase the quantity and quality of cancer research throughout the world. mlodge AT